3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Gastrointestinal
1
Conditions
Tumor Lysis Syndrome
1
Tongue Neoplasms
1
Thyroid cancer, Hurthle cell
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Thromboembolism
1
Teratogenesis
1
Squamous Cell Carcinoma of Head and Neck
1
Sleepiness
1
Seizures
1
Salivary Gland Neoplasms
1
Renal Insufficiency
1
Rectal Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Peripheral Nervous System Diseases
1
Neoplasms, Second Primary
1
Lymphoma
1
Lymphoid Interstitial Pneumonia
1
Lung Diseases, Interstitial
1
Infections
1
Hypothyroidism
1
Hypotension, Orthostatic
1
Hypersensitivity
1
Hemorrhage
1
Heart Failure
1
Head and Neck Neoplasms
1
Fatigue
1
Dizziness
1
Digestive System Diseases
1
Coronary Artery Disease
1
Interventions
Cetuximab
16
Cisplatin
15
Radiotherapy, Intensity-Modulated
10
Radiotherapy
6
Docetaxel
6
Erlotinib Hydrochloride
5
Fluorouracil
4
Everolimus
4
Carboplatin
4
Sorafenib
3
Radiation
3
Paclitaxel
3
Fluorodeoxyglucose F18
3
Chemotherapy, Adjuvant
3
Biopsy
3
Albumin-Bound Paclitaxel
3
130-nm albumin-bound paclitaxel
3
Taxes
2
Sirolimus
2
Radiotherapy, Conformal
2
Psychiatric Rehabilitation
2
Platinum
2
Photochemotherapy
2
Microarray Analysis
2
Magnetic Resonance Spectroscopy
2
Immunohistochemistry
2
Gene Expression Profiling
2
Drug Therapy
2
Celecoxib
2
Bevacizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Tongue Neoplasms
×
Lenalidomide
×
Head & Neck
×
Clear all
NCT01254617
2020-03-13
ADCC
National Cancer Institute (NCI)
Phase 1
Completed
24 enrolled